We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Variants Linked to Bowel Cancer

By LabMedica International staff writers
Posted on 09 Dec 2010
Print article
Four new genetic variants linked to colorectal cancer have been discovered by combining data from three major genome studies.

Pooling the data from these studies created the largest study of its kind, involving over 45,000 volunteers with and without bowel cancer, allowing previously undetected genetic sites to be pinpointed.

In a collaborative study, British scientists scoured the genomes of 3,334 bowel cancer patients and 4,628 people without the disease from across the UK, using DNA extracted from blood samples. Comparing the genomes of people with and without the disease allowed them to identify a total of seven different one-letter alterations in the genetic code (single nucleotide polymorphisms), where genes involved in the development of bowel cancer were most likely to be found.

To confirm their finding they then looked at an additional 18,095 bowel cancer patients and 20,197 people without bowel cancer. Four of the seven genetic sites were clearly associated with small but significantly raised risk of bowel cancer among the general population, bringing the total number identified to fourteen. The Cancer Research UK, (London, UK) funded the study and is behind all fourteen of the gene variants that have so far been linked to bowel cancer which have been identified as the result of ten years of investigations.

Richard Houlston, MD PhD, from the Institute of Cancer Research, (Sutton, UK) and senior author of the study, said, "Our study identifies four completely new genetic variants that can influence a person's risk of developing bowel cancer, suggesting that even more variants linked to bowel cancer are yet to be discovered.

Although each of these variants has only a small impact on a person's risk of developing the disease, there is now genuine hope that as more pieces of the jigsaw are discovered, identifying those who are at highest risk, helping to find better target measures to prevent the cancer, or detect it earlier maximizes the chance of treatment being successful. The study was published online October 24, 2010 in Nature Genetics.

Related Links:
Cancer Research UK
Institute of Cancer Research


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Unit-Dose Packaging solution
HLX
New
Gold Member
Total Triiodothyronine Assay
T3 EIA 96 Kit
New
Control Material
Blood Culture Identification Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.